Home HealthCare Roka Bioscience Declares Transition of CEO Role from Paul Thomas to Mary...

Roka Bioscience Declares Transition of CEO Role from Paul Thomas to Mary Duseau;


News: Roka Bioscience Inc (NASDAQ:ROKA) belongs to Healthcare sector and Medical Laboratories & Research industry. Roka Bioscience, Inc. (NASDAQ: ROKA), a sub-atomic diagnostics organization concentrated on giving propelled testing answers for the discovery of foodborne pathogens as of late announced the arrangement of Mary Duseau as President and CEO. Ms. Duseau succeeds Paul Thomas, the Company’s President and CEO since 2009, who will take on the position as Chairman of the Company’s Board of Directors. The progressions are viable as of late.

Also, Ms. Duseau will join the Company’s Board of Directors, successful as of late.

“I am glad for what our group has finished since we began Roka seven years prior, and I immovably trust we are all around situated to exploit the expanding requests from buyers and controllers to guarantee a protected sustenance supply. I anticipate keep working with Mary in our new parts,” Paul Thomas said.

“I am eager to be a piece of Roka when utilizing the best innovation to forestall foodborne sickness is more critical than any time in recent memory to the sustenance business,” Duseau said. “We have situated Roka as an accomplice to both the nourishment providers and to the business research facilities, offering both mechanical favorable circumstances and noteworthycost advantages to the sustenance security industry with our exact and robotized Atlas® framework,” proceeded with Ms. Duseau.

Mary Duseau, 51, has served as Senior Vice President, Chief Commercial Officer of Roka Bioscience since February 2015. From October 2012 until January 2015, Ms. Duseau served as Global Sales Director and on the board at Andor Technology plc (“Andor”), a division of Oxford Instruments plc, a pioneer in the worldwide logical computerized camera advertise. Before joining Andor, Ms. Duseau held different deals and organization parts of expanding duty with PerkinElmer, Inc. from 2000 through September 2012, including the position of Vice-President Sales and Marketing, Bio-disclosure, from 2008 to September 2012, where she drove the deals and promoting of the organization’s life science devices business. Ms. Duseau got her Bachelor of Science in Biochemistry with a minor in Neuroscience from the University of Massachusetts, Amherst.

Summary: Roka Bioscience is an atomic diagnostics organization concentrated on creating and commercializing propelled testing answers for the nourishment security testing market. Our Atlas Detection Assays fuse our progressed atomic advances and are performed on our “example in, result-out” Atlas System that computerizes all parts of sub-atomic symptomatic testing on a solitary, incorporated stage. The Atlas System and Detection Assays are intended to give our clients exact and quick test comes about with lessened work costs and enhanced research center efficiencies.